kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Allied Telesis Holdings KK
6835
Wintest
6721
(FY)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 39.43%46.18B | -35.25%7.75B | 4.75%13.82B | 59.91%-3.87B | -27.17%33.12B | 17.61B | -30.84%11.96B | 146.08%13.2B | -961.50%-9.65B | 20.14%45.48B |
Net profit before non-cash adjustment | 44.13%32.25B | -41.82%4.06B | 111.42%9.7B | 120.26%5.82B | -28.50%22.38B | --8.16B | -22.04%6.99B | -1.84%4.59B | -76.15%2.64B | -8.20%31.29B |
Total adjustment of non-cash items | -18.81%16.72B | 64.93%13.43B | -94.86%228M | -49.83%862M | 46.50%20.59B | --6.3B | 9.35%8.14B | 83.88%4.44B | 185.94%1.72B | 28.12%14.06B |
-Depreciation and amortization | 4.76%21.16B | 2.79%5.3B | 0.49%5.14B | 6.13%5.2B | 14.36%20.2B | --5.03B | 24.92%5.16B | 18.71%5.11B | 21.61%4.9B | 23.95%17.67B |
-Reversal of impairment losses recognized in profit and loss | 3,471.12%6.68B | 8,985.51%6.27B | -50.00%6M | --3M | -62.67%187M | --106M | -1.43%69M | -82.09%12M | --0 | 3,240.00%501M |
-Share of associates | -81.77%-2.92B | -24.83%-739M | -106.80%-699M | -77.00%-754M | 11.90%-1.61B | ---251M | -36.09%-592M | 31.72%-338M | 26.68%-426M | 18.17%-1.82B |
-Disposal profit | -1,163.13%-7.61B | -919.17%-983M | -2,054.44%-3.3B | -71.26%50M | 114.52%716M | --253M | 50.00%120M | 131.51%169M | 103.31%174M | -1,422.25%-4.93B |
-Other non-cash items | -153.51%-587M | 5.64%3.58B | -75.96%-915M | -24.16%-3.63B | -58.56%1.1B | --1.16B | -5.97%3.38B | 66.23%-520M | -459.46%-2.93B | 283.95%2.65B |
Changes in working capital | 71.68%-2.79B | -208.19%-9.74B | -6.62%3.89B | 24.71%-10.55B | -7,855.12%-9.85B | --3.15B | -452.79%-3.16B | 341.74%4.17B | -40.29%-14.01B | 101.76%127M |
-Change in receivables | 177.83%1.91B | 166.33%7.49B | -93.86%-3.44B | -27.67%6.14B | -347.38%-2.45B | --2.13B | -1,522.67%-11.3B | 72.41%-1.78B | -31.60%8.49B | 113.96%992M |
-Change in inventory | 413.02%4.14B | 80.72%-70M | 10.59%3.33B | 28.17%-5.67B | -24.04%-1.32B | --3.92B | -140.51%-363M | 232.34%3.01B | -77.41%-7.89B | 81.76%-1.07B |
-Change in payables | -134.23%-9.33B | -301.06%-17.53B | 14.92%3.71B | 27.40%-10.44B | -357.70%-3.98B | ---1.54B | 785.30%8.72B | -4.45%3.22B | 21.78%-14.39B | -122.10%-870M |
-Provision for loans, leases and other losses | ---- | --361M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Changes in other current assets | 123.57%493M | ---- | 204.50%302M | -164.06%-573M | -295.51%-2.09B | ---1.37B | -145.82%-219M | -166.90%-289M | -148.33%-217M | -40.59%1.07B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -138.89%-43M | -42.86%-10M | 33.33%-6M | -271.43%-26M | 56.10%-18M | 5M | -16.67%-7M | 40.00%-9M | 0.00%-7M | -20.59%-41M |
Interest received (cash flow from operating activities) | 51.18%2.55B | 253.42%1.14B | -16.18%751M | 61.97%230M | 6.03%1.69B | 328M | 106.41%322M | -20.28%896M | 37.86%142M | 6.85%1.59B |
Tax refund paid | -6.57%-5.03B | 5.44%-2.17B | -242.43%-433M | 15.18%-1.47B | 6.81%-4.72B | -994M | 32.43%-2.3B | -87.29%304M | 49.62%-1.73B | 74.69%-5.07B |
Other operating cash inflow (outflow) | 300.00%2M | 66.67%-1M | 0 | 0 | -200.00%-1M | 2M | -3M | 300.00%2M | -100.00%-2M | 1M |
Operating cash flow | 45.20%43.66B | -32.84%6.7B | -1.77%14.13B | 54.36%-5.13B | -28.34%30.07B | --16.95B | -28.98%9.98B | 62.37%14.39B | -164.43%-11.25B | 117.46%41.96B |
Investing cash flow | ||||||||||
Capital expenditures | --0 | --0 | --0 | --0 | ---- | ---- | --21M | ---30M | ---397M | ---- |
Net PPE purchase and sale | 71.10%-6.72B | 101.95%148M | 46.73%-4.05B | -14.42%-4.13B | -79.24%-23.25B | ---4.43B | -47.32%-7.6B | -25.07%-7.61B | -272.38%-3.61B | 65.16%-12.97B |
Net intangibles purchase and sale | 25.73%-938M | 28.57%-200M | 51.54%-173M | 13.45%-193M | 72.87%-1.26B | ---403M | -75.00%-280M | 66.73%-357M | 92.68%-223M | 17.45%-4.66B |
Net business purchase and sale | 98.32%-102M | --0 | --3.07B | 106.97%494M | -9,870.49%-6.08B | --1.01B | --0 | --0 | -7,282.29%-7.09B | -101.98%-61M |
Net investment product transactions | 15.07%-3.08B | 15.82%-1.13B | 324.19%1.18B | 11.81%-1.25B | -275.05%-3.62B | ---338M | -297.65%-1.35B | -162.50%-525M | -10.64%-1.41B | -116.21%-966M |
Repayment of advance payments to other parties and cash income from loans | --3.66B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net changes in other investments | 15.60%-487M | -48.39%-138M | 143.88%43M | 50.00%-8M | 34.73%-577M | ---370M | -38.81%-93M | -117.38%-98M | 97.44%-16M | -154.02%-884M |
Investing cash flow | 77.99%-7.66B | 85.77%-1.32B | 100.71%61M | 60.09%-5.09B | -78.09%-34.79B | ---4.13B | -97.66%-9.29B | -50.73%-8.62B | -332.20%-12.75B | 42.84%-19.54B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 89.65%-149M | 166.67%2M | -8.57%-152M | --0 | -425.55%-1.44B | ---147M | -200.00%-3M | -3.70%-140M | ---1.15B | -5.79%-274M |
Net common stock issuance | -1,000,100.00%-10B | ---1M | --0 | ---10B | 99.99%-1M | ---1M | --0 | --0 | --0 | ---10B |
Increase or decrease of lease financing | -3.86%-2.72B | 1.57%-688M | 10.09%-722M | -30.24%-590M | -74.07%-2.62B | ---663M | -79.23%-699M | -127.48%-803M | -20.48%-453M | -3.30%-1.5B |
Cash dividends paid | 1.30%-7.29B | 2.81%-3.6B | -7.69%12M | -0.11%-3.71B | -7.11%-7.39B | --12M | -8.42%-3.71B | 18.18%13M | -5.89%-3.7B | 1.13%-6.9B |
Cash dividends for minorities | -101.76%-1.49B | --0 | ---- | ---- | 36.70%-740M | ---187M | --0 | ---- | ---- | 24.04%-1.17B |
Net other fund-raising expenses | 5.92%447M | --208M | 0.00%-2M | -100.63%-1M | 1,818.18%422M | --266M | --0 | -100.00%-2M | 15,900.00%158M | 633.33%22M |
Financing cash flow | -80.28%-21.21B | 7.42%-4.08B | -41.28%-2.1B | -177.74%-14.3B | 40.66%-11.76B | ---720M | -16.49%-4.41B | 5.47%-1.49B | 62.89%-5.15B | -93.85%-19.82B |
Net cash flow | ||||||||||
Beginning cash position | -15.39%85.53B | -2.86%74.97B | -14.42%61.75B | -15.39%85.53B | 3.94%101.08B | --73.84B | -2.73%77.18B | -6.20%72.16B | 3.94%101.08B | -19.98%97.25B |
Current changes in cash | 189.76%14.8B | 134.79%1.3B | 182.38%12.1B | 15.87%-24.52B | -732.54%-16.48B | --12.1B | -166.97%-3.73B | 172.52%4.28B | -38.28%-29.15B | 110.38%2.61B |
Effect of exchange rate changes | 106.02%1.92B | -438.96%-1.31B | 52.72%1.12B | 228.19%745M | -23.81%931M | ---415M | 90.59%385M | -13.14%734M | -69.93%227M | 48.66%1.22B |
Cash adjustments other than cash changes | ---- | ---- | ---- | 0.00%-1M | --1M | ---- | ---- | ---- | 0.00%-1M | ---- |
End cash Position | 19.54%102.24B | 1.52%74.96B | -2.86%74.97B | -14.42%61.75B | -15.39%85.53B | --85.53B | -13.25%73.84B | -2.73%77.18B | -6.20%72.16B | 3.94%101.08B |
Free cash flow | 385.24%24.66B | -103.06%-65M | 55.25%9.91B | 38.89%-9.46B | -72.99%5.08B | --12.06B | -75.65%2.13B | 274.97%6.38B | -44.72%-15.48B | 179.65%18.82B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |